Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
Katey J. Rayner(University of Ottawa), Kathryn J. Moore(New York University), Saj Parathath(New York University), Christine Esau(Ionis Pharmaceuticals (United States)), Janine M. van Gils(Leiden University Medical Center), Carlos Fernández‐Hernando(Yale University), Ryan E. Temel(University of Kentucky), Alistair Rayner(New York University), Aaron N. Chang(Baylor University Medical Center), Edward A. Fisher(Mount Sinai Hospital), Yajaira Suárez(Yale University), Farah Hussain(New York University), Frederick J. Sheedy(Trinity College Dublin)
Cited by 686
Related Papers
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|Nature|2010|4k
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
|Cell Metabolism|2006|2.1k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
|Nature Immunology|2009|1.5k